MANKINDUpdated 1 Sept 2026, 2:54

Mankind Pharma Limited

MANKINDUpdated 1 Sept 2026, 2:54

Market Cap

₹99,724Cr.

Current Price

₹2,419

High / Low

₹2,674/1,910

Stock P/E

44.1

ROE13.8%

ROCE13.7%

Book Value₹397

Face Value₹1.00

Dividend Yield0.04%

About

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	23	13	32	24	23	22	33	35	41
Inventory Days	120	126	124	169	183	132	160	154	151
Days Payable	115	101	113	122	133	103	75	80	95
Cash Conversion Cycle	27	38	43	72	73	52	118	109	97
Working Capital Days	95	44	41	42	26	40	55	-81	-87
ROCE %	—	22%	36%	33%	30%	21%	24%	15%	14%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 2:54

MANKIND PHARMA LIMITED (MANKIND) financials — quarterly results, P&L, cash flow, balance sheet, shareholding